In line with these results, previous studies suggested a role for LTβR signaling in control of CXCL1 and CXCL2 expression in response to mucosal bacterial pathogens (66) and suppression of metabolic activation via neutrophil-intrinsic LTβR signaling during colitis (59). The gene discussed is CXCL2; the disease is colitis.